Clinical Trial

Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk

Study acronym: MPH-ATX
Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated August 9, 2024 (before its estimated September 25, 2025 completion). Its status may not reflect the trial's current state.
Summary
The study team will examine the effects of FDA approved stimulant and non-stimulant medications for ADHD, among youth with ADHD and with and without Oppositional Defiant Disorder (ODD) or Conduct Disorder (CD), on reward systems of the brain using fMRI.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2018-12-18; most recent amendment 2024-08-06.
Status change: Active, Not Recruiting → Recruiting 2021-03-23
Status change: Recruiting → Active, Not Recruiting 2020-04-15
Status change: Not Yet Recruiting → Recruiting 2019-08-14
Trial Details
NCT Number NCT03781765
Lead Sponsor Icahn School of Medicine at Mount Sinai
Collaborators: National Institute on Drug Abuse (NIDA)
Conditions ADHD, Attention Deficit Hyperactivity Disorder
Enrollment 44 participants
Start Date 2019-06-04
Primary Completion 2025-09-25 (estimated)
Study Completion 2025-09-25 (estimated)
Updated on ClinicalTrials.gov 2024-08-09